Neurohormonal activation induces intracellular iron deficiency and mitochondrial dysfunction in cardiac cells

M Tajes1,2, C Díez-López1,2,3,4, C Enjuanes1,2,5

  • 1Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

Cell & Bioscience
|May 18, 2021
PubMed

Insights

Heart failure neurohormonal activation disrupts iron balance and impairs heart cell mitochondria. This study reveals a potential link between iron dysregulation and heart failure pathophysiology.

Area of Science:

  • Cardiology
  • Mitochondrial Biology
  • Iron Metabolism

Background:

  • Iron deficiency is prevalent in heart failure (HF) patients, linked to adverse outcomes.
  • The precise role of iron in HF pathophysiology remains unclear.
  • Neurohormonal activation is a hallmark of HF.

Purpose of the Study:

  • To investigate the impact of HF-associated neurohormonal activation on iron homeostasis.
  • To examine the effects on mitochondrial function within cardiac cells.

Main Methods:

  • Induced heart failure in mice using isoproterenol and challenged cardiac cell lines (H9c2) with angiotensin II/norepinephrine.
  • Assessed gene and protein expression of iron metabolism regulators via Real-time PCR and immunoblotting.
  • Analyzed intracellular iron levels and mitochondrial function (membrane potential, ROS, ATP production).

Main Results:

  • Neurohormonal activation decreased key iron regulatory proteins (TfR1, ferroportin 1, hepcidin) and mitochondrial iron transporters (mitoferrin 2, mitochondrial ferritin) in mice and cell models.
  • Observed reduced intracellular iron levels in stimulated cells and HF mouse hearts.
  • Demonstrated impaired mitochondrial function, including increased ROS, decreased membrane potential, and reduced ATP production.

Conclusions:

  • HF neurohormonal activation dysregulates iron homeostasis and impairs cardiac mitochondrial function.
  • These findings suggest a significant role for iron dysregulation in the pathophysiology of heart failure.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
125
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
16.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
144
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
645